In livestreamed FDA meeting, U.S. regulators and experts take up Covid vaccine issues

Photo caption: Pfizer’s Covid-19 vaccine clinical trial at the University of Maryland School of Medicine in Baltimore on May 4, 2020. University of Maryland via AP. Article by The Associated Press.

The meeting offers insights into the FDA’s vaccine approval process.

WASHINGTON — The U.S. regulators who will decide the fate of Covid-19 vaccines took an unusual step Thursday: Asking outside scientists if their standards are high enough.

The Food and Drug Administration may have to decide by year’s end whether to allow use of the first vaccines against the coronavirus. Thursday, a federal advisory committee began pulling back the curtain on that decision process, debating whether the guidelines FDA has set for vaccine developers are rigorous enough. […]

Click here to view original web page at www.nbcnews.com